ÂÜÀòÂÒÂ×

Ivan Krivega is a Senior Director at SonoThera, with a background in gene therapy for liver, kidney, heart, and pancreatic disorders. Prior to their current role, Ivan held positions at BioMarin Pharmaceutical Inc. and Sangamo Therapeutics, where Ivan worked on developing non-viral gene therapy platforms for various disorders. With a solid research background, including a PhD in Molecular genetics, Ivan has been involved in drug development and therapeutic strategies for a wide range of medical conditions. Additionally, Ivan has experience as a Patent Examiner and has worked as a Researcher and Research Assistant in academic settings.